Irritable bowel syndrome (IBS) is a functional gut disorder the diagnosis of which is based on
clinical symptoms as set forth by the Rome criteria. As the population ages, especially with …

The irritable bowel syndrome (IBS) is part of the spectrum of functional bowel disorders
characterised by a diverse consortium of abdominal symptoms including abdominal pain …

The irritable bowel syndrome (IBS) is a consortium of symptoms including abdominal pain
and alterations in the pattern of defaecation. There is no single pathophysiological marker of …

The therapeutic management of the irritable bowel syndrome (IBS) is ineffective and not
satisfying either patients or practitioners. Research in functions of the enteric nervous system …

Irritable bowel syndrome (IBS) is the most common condition that a physician faces in the GI
clinic. Of the general population, 10-25% suffer from symptoms judged to be IBS. The …

Irritable bowel syndrome (IBS) is a remarkably frequent disorder that leads to relevant
impairment in patients' quality of life. Four mechanisms are involved in the pathogenesis of …

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder whose aetiology is
still unknown. Most hypotheses point out the gut-brain axis as a key factor for IBS. The axis is …

Irritable bowel syndrome (IBS) is a highly prevalent functional gastrointestinal disorder
affecting up to 3–15% of the general population in Western countries. It is characterised by …

Irritable bowel syndrome (IBS) is defined as a functional bowel disorder in which abdominal
pain is associated with defecation or a change in bowel habit, and with features of …

Antidepressants rapidly relieve pain in irritable bowel syndrome (IBS) and are effective at
low doses. Noradrenaline reuptake inhibitors appear to be more effective than selective …